title: [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
abstract: Beta-blockers are among the most important groups of drugs for glaucoma                         therapy. The advantages of beta-blockers are a good efficacy in primary and                         secondary types of glaucoma, different dosages, clinical experiences over                         decades, easy use in combination with all other glaucoma drugs, and low                         costs. Timolol is the most frequently used drug in fixed glaucoma                         medications. In comparison with other glaucoma drugs, beta-blockers have the                         most severe systemic side effects and may interact with other systemic                         medication.
authors: Ophthalmology, Tagesklinik Ambimed, Klingentalstrasse 9, Basel, Switzerland. tschlote@bluewin.ch
authors: T
authors: T
authors: Schlote
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005901:Glaucoma / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology*; D009883:Ophthalmic Solutions; D013999:Timolol / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D013999:Timolol